Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Quiz

Understanding the Arexvy RSV Vaccine

"A single dose of the RSVPreF3 OA vaccine had an acceptable safety profile and prevented RSV-related acute respiratory infection and lower respiratory tract disease and severe RSV-related lower respiratory tract disease in adults 60 years of age or older, regardless of RSV subtype and the presence of underlying coexisting conditions," said researchers. To learn more about RSV vaccines, visit the topic center.

Advertisement

Advertisement

Advertisement